Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BARD C R INC /NJ/BCR · Entity 170698 | Director | December 29, 2017 | January 03, 2018 |
| Carlyle Group Inc.CG · Entity 3316 | Director | May 01, 2026 | May 01, 2026 |
| GILEAD SCIENCES, INC.GILD · Entity 405 | Director | August 26, 2026 | August 27, 2026 |
| LOEWS CORPL · Entity 3231 | Director | March 03, 2025 | March 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BARD C R INC /NJ/
Report date December 29, 2017 · Filed January 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 1
1 source rowRow 1 · 2017-12-29 · Disposition to issuer · Disposed 4,520 · Balance 0 F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 20,596.9 |
Reported balance
After 2017-12-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-12-29 · Grant · Acquired 83.42 · Balance 20,596.9 F2: Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees. F3: Conversion is 1 for 1. F4: Phantom stock units are settled in cash upon termination of service as director. F5: Includes 32.86 units for dividend credits. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-12-29 · Disposition to issuer · Disposed 20,596.9 · Balance 0 F2: Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees. F3: Conversion is 1 for 1. F6: These units, which are 100% vested, were paid out in cash in accordance with the Merger Agreement. |
| Share Equivalent UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-12-29 · Disposition to issuer · Disposed 17,808 · Balance 0 F7: Units granted under the Company's Stock Equivalent Plan for Outside Directors. F3: Conversion is 1 for 1. F8: These units, which are 100% vested, were assumed by BD at the effective time of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration").
F2: Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees.
F3: Conversion is 1 for 1.
F4: Phantom stock units are settled in cash upon termination of service as director.
F5: Includes 32.86 units for dividend credits.
F6: These units, which are 100% vested, were paid out in cash in accordance with the Merger Agreement.
F7: Units granted under the Company's Stock Equivalent Plan for Outside Directors.
F8: These units, which are 100% vested, were assumed by BD at the effective time of the Merger.
Carlyle Group Inc.
Report date May 01, 2026 · Filed May 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,849 |
Reported balance
After 2026-05-01 transaction · row 1
1 source rowRow 1 · 2026-05-01 · Grant · Acquired 4,450 · Balance 47,849 F1: These securities are a restricted stock unit award granted under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan. These securities will vest on May 1, 2027, subject to the reporting person's continued service on the Issuer's Board of Directors on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are a restricted stock unit award granted under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan. These securities will vest on May 1, 2027, subject to the reporting person's continued service on the Issuer's Board of Directors on such vesting date.
GILEAD SCIENCES, INC.
Report date August 26, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,894 |
Ending reported balance
After 2026-08-26 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2026-08-26 · Exercise / conversion · Acquired 7,718 · Balance 20,612 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. Row 2 · 2026-08-26 · Sale · Disposed 3,118 · Balance 17,494 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F2: Sale prices for the transactions reported range from $147.58 to $148.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Row 3 · 2026-08-26 · Sale · Disposed 4,600 · Balance 12,894 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F3: Sale prices for the transactions reported range from $148.58 to $149.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Row 4 · 2026-08-26 · Exercise / conversion · Acquired 10,282 · Balance 23,176 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. Row 5 · 2026-08-26 · Sale · Disposed 3,402 · Balance 19,774 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F4: Sale prices for the transactions reported range from $147.57 to $148.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Row 6 · 2026-08-26 · Sale · Disposed 6,880 · Balance 12,894 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F5: Sale prices for the transactions reported range from $148.57 to $149.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.67 · Expires 2030-10-22 | Direct | 0 |
Reported balance
After 2026-08-26 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-26 · Exercise / conversion · Disposed 7,718 · Balance 0 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F6: 100% of the shares subject to the stock option vested immediately upon the grant date of October 22, 2020. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.35 · Expires 2032-05-05 | Direct | 5,569 |
Reported balance
After 2026-08-26 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-26 · Exercise / conversion · Disposed 10,282 · Balance 5,569 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F7: 25% of the shares subject to the option vested on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option were fully vested and exercisable on October 22, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026.
F2: Sale prices for the transactions reported range from $147.58 to $148.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F3: Sale prices for the transactions reported range from $148.58 to $149.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F4: Sale prices for the transactions reported range from $147.57 to $148.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F5: Sale prices for the transactions reported range from $148.57 to $149.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F6: 100% of the shares subject to the stock option vested immediately upon the grant date of October 22, 2020.
F7: 25% of the shares subject to the option vested on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option were fully vested and exercisable on October 22, 2021.
LOEWS CORP
Report date March 03, 2025 · Filed March 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,845 |
Ending reported balance
After 2025-03-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-03-03 · Exercise / conversion · Acquired 2,250 · Balance 12,095 F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024. Row 2 · 2025-03-03 · Disposition to issuer · Disposed 1,053 · Balance 11,042 F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024. Row 3 · 2025-03-03 · Sale · Disposed 1,197 · Balance 9,845 F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024. |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $40.61 · Expires 2025-03-31 | Direct | 0 |
Reported balance
After 2025-03-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-03-03 · Exercise / conversion · Disposed 2,250 · Balance 0 F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024. F2: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024.
F2: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
UNITEDHEALTH GROUP INC
Report date June 05, 2012 · Filed June 07, 2012
Section 16 reporting ended · disclosed 2012-06-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 119,908.836 |
Reported balance
After 2012-06-05 transaction · row 1
1 source rowRow 1 · 2012-06-05 · Tax withholding · Disposed 7,211 · Balance 119,908.836 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2023 Filed May 4, 2023 21:47 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 10,173 | $79.45 Strike: $79.45 | $808,244.85 |
DisclosureSEC source: 0001127602-23-014544 · form4.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,173 Underlying: Common Stock · 10,173 shares Expires 2033-05-03 F2 · derivative.exercise_date: 100% of the shares subject to the stock option vested immediately upon the grant date of May 3, 2023. Read SEC document |
| May 03, 2023 Filed May 4, 2023 21:47 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantCommon Stock | 1,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014544 · form4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,922 F1 · security: Represents 1,887 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 3, 2023. Read SEC document |
| May 01, 2023 Filed May 3, 2023 21:04 UTC | Carlyle Group Inc. CG · Entity 3316 | GrantCommon Stock | 6,238 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-012098 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,346 F1 · shares: These securities are restricted stock unit awards granted under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan. These securities will vest on May 1, 2024, subject to the reporting person's continued service on the Board of Directors of The Carlyle Group Inc. on such vesting date. Read SEC document |
| December 21, 2022 Filed Dec 22, 2022 15:23 UTC | LOEWS CORP L · Entity 3231 | GiftCommon Stock | 877 | $0.00 | $0.00 |
DisclosureSEC source: 0000060086-22-000135 · wf-form4_167172261458843.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,572 Read SEC document |
| May 11, 2022 Filed May 11, 2022 19:54 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0000060086-22-000043 · wf-form4_165229886073100.xml · derivative · entry 3 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,725 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 11, 2021, the Reporting Person was granted 1,725 RSUs, which vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. F4 · derivative.expiration_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 11, 2021, the Reporting Person was granted 1,725 RSUs, which vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. Read SEC document |
| May 11, 2022 Filed May 11, 2022 19:54 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0000060086-22-000043 · wf-form4_165229886073100.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: Represents the conversion into common stock upon vesting of previously awarded restricted stock units ("RSUs"). Read SEC document |
| May 10, 2022 Filed May 11, 2022 19:54 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 1,567 | $0.00 | $0.00 |
DisclosureSEC source: 0000060086-22-000043 · wf-form4_165229886073100.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,567 Underlying: Common Stock · 1,567 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest on May 10, 2023. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F3 · derivative.expiration_date: The RSUs vest on May 10, 2023. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| May 05, 2022 Filed May 6, 2022 22:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 15,851 | $0.00 Strike: $61.35 | $0.00 |
DisclosureSEC source: 0001127602-22-013720 · form4.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,851 Underlying: Common Stock · 15,851 shares Expires 2032-05-05 F2 · derivative.exercise_date: 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. Read SEC document |
| May 05, 2022 Filed May 6, 2022 22:45 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantCommon Stock | 2,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-013720 · form4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,035 F1 · security: Represents 2.444 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 5, 2022. Read SEC document |
| May 03, 2022 Filed May 4, 2022 00:00 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 2,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-013114 · form4.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,223 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 3, 2022. F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 3, 2022. Read SEC document |
| May 03, 2022 Filed May 4, 2022 00:00 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 2,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-013114 · form4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| May 01, 2022 Filed May 2, 2022 22:12 UTC | Carlyle Group Inc. CG · Entity 3316 | GrantCommon Stock | 5,236 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-016153 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,108 F1 · shares: These securities are restricted stock unit awards granted under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan. These securities will vest on May 1, 2023, subject to the reporting person's continued service on the Board of Directors of The Carlyle Group Inc. on such vesting date. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 13:36 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 1,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-000129 · doc1.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,959 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 8, 2018, the Reporting Person was granted 1,952 RSUs, which, together with additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with such RSUs, vested on the first anniversary of the grant date. The Reporting Person elected to defer delivery of the common stock into which such RSUs vested until January 1, 2022. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. F3 · derivative.expiration_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 8, 2018, the Reporting Person was granted 1,952 RSUs, which, together with additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with such RSUs, vested on the first anniversary of the grant date. The Reporting Person elected to defer delivery of the common stock into which such RSUs vested until January 1, 2022. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 13:36 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-000129 · doc1.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: Represents the conversion into common stock upon vesting of previously awarded restricted stock units ("RSUs"). Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 15:05 UTC | LOEWS CORP L · Entity 3231 | GiftCommon Stock | 1,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-022139 · doc1.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,765 Read SEC document |
| December 13, 2021 Filed Dec 13, 2021 19:02 UTC | LOEWS CORP L · Entity 3231 | GiftCommon Stock | 5,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-021921 · doc1.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,520 Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 23:15 UTC | Carlyle Group Inc. CG · Entity 3316 | GiftCommon Stock | 10,951 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-047803 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,872 F1 · kind: Reflects charitable donations by the Reporting Person. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 19:31 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 1,368 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-027629 · form4.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,223 Underlying: Common Stock · 1,368 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vested on October 22, 2021. F2 · derivative.expiration_date: 100% of the restricted stock units vested on October 22, 2021. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 19:31 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 1,368 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-027629 · form4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| August 31, 2021 Filed Sep 3, 2021 20:30 UTC | Carlyle Group Inc. CG · Entity 3316 | GiftCommon Stock | 1,530 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-035125 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,823 F1 · kind: Reflects a charitable donation by the Reporting Person. Read SEC document |
| May 12, 2021 Filed May 12, 2021 15:12 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 3,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-009647 · doc1.xml · derivative · entry 3 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,292 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 12, 2020, the Reporting Person was granted 3,292 RSUs, which vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. F4 · derivative.expiration_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 12, 2020, the Reporting Person was granted 3,292 RSUs, which vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. Read SEC document |
| May 12, 2021 Filed May 12, 2021 15:12 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 3,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-009647 · doc1.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: Represents the conversion into common stock upon vesting of previously awarded restricted stock units ("RSUs"). Read SEC document |
| May 12, 2021 Filed May 14, 2021 19:56 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 14,665 | $0.00 Strike: $67.45 | $0.00 |
DisclosureSEC source: 0001127602-21-016781 · form4.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,665 Underlying: Common Stock · 14,665 shares Expires 2031-05-12 F3 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 12, 2021 Filed May 14, 2021 19:56 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Unit · Derivative | 2,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-016781 · form4.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,591 Underlying: Common Stock · 2,223 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units will vest on the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting. F2 · derivative.expiration_date: 100% of the restricted stock units will vest on the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 11, 2021 Filed May 12, 2021 15:12 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-009647 · doc1.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 Underlying: Common Stock · 1,725 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest on May 11, 2022. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F3 · derivative.expiration_date: The RSUs vest on May 11, 2022. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| May 01, 2021 Filed May 4, 2021 01:28 UTC | Carlyle Group Inc. CG · Entity 3316 | GrantCommon Stock | 3,985 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-017942 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,353 F1 · shares: These securities are restricted stock unit awards granted under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan. These securities will vest on May 1, 2022, subject to the reporting person's continued service on the Board of Directors of The Carlyle Group Inc. on such vesting date. Read SEC document |
| October 22, 2020 Filed Oct 26, 2020 23:12 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 7,718 | $0.00 Strike: $60.67 | $0.00 |
DisclosureSEC source: 0001127602-20-027542 · form4.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,718 Underlying: Common Stock · 7,718 shares Expires 2030-10-22 F3 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable on October 22, 2021. Read SEC document |
| October 22, 2020 Filed Oct 26, 2020 23:12 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Unit · Derivative | 1,368 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-027542 · form4.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 Underlying: Common Stock · 1,368 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units will vest on October 22, 2021. F2 · derivative.expiration_date: 100% of the restricted stock units will vest on October 22, 2021. Read SEC document |
| May 14, 2020 Filed May 14, 2020 12:44 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 1,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-009925 · doc1.xml · derivative · entry 3 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,979 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 14, 2019, the Reporting Person was granted 1,979 RSUs which vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. F4 · derivative.expiration_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 14, 2019, the Reporting Person was granted 1,979 RSUs which vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. Read SEC document |
| May 14, 2020 Filed May 14, 2020 12:44 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-009925 · doc1.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: Represents the conversion into common stock upon vesting of previously awarded restricted stock units ("RSUs"). Read SEC document |
| May 12, 2020 Filed May 14, 2020 12:44 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 3,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-009925 · doc1.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,292 Underlying: Common Stock · 3,292 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest on May 12, 2021, and shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F3 · derivative.expiration_date: The RSUs vest on May 12, 2021, and shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| May 01, 2020 Filed May 5, 2020 22:48 UTC | Carlyle Group Inc. CG · Entity 3316 | GrantCommon Stock | 5,411 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-012097 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,368 F1 · security: On January 1, 2020, The Carlyle Group L.P., a Delaware limited partnership, converted into a Delaware corporation named The Carlyle Group Inc. As a result of such conversion, each common unit of limited partner interest of The Carlyle Group L.P. converted into a share of common stock of The Carlyle Group Inc. F2 · shares: These securities are restricted stock unit awards granted under The Carlyle Group Inc. 2012 Amended & Restated Equity Incentive Plan. These securities will vest on May 1, 2021, subject to Mr. Welters's continued service on the board of directors of The Carlyle Group Inc. on such vesting date. Read SEC document |
| May 14, 2019 Filed May 14, 2019 20:38 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 1,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-010845 · doc1.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,979 Underlying: Common Stock · 1,979 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (each, an "RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vest on May 14, 2020. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F2 · derivative.expiration_date: The RSUs vest on May 14, 2020. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| May 01, 2019 Filed May 3, 2019 21:03 UTC | Carlyle Group Inc. CG · Entity 3316 | GrantCommon Units | 5,854 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-012035 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,957 F1 · shares: These securities are deferred restricted common unit awards granted under The Carlyle Group L.P. 2012 Equity Incentive Plan. These securities will vest on May 1, 2020, subject to Mr. Welters's continued service on the board of directors of Carlyle Group Management L.L.C., the general partner of The Carlyle Group L.P., on such vesting date. Read SEC document |
| December 11, 2018 Filed Dec 13, 2018 21:42 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.7 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-007923 · doc1.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,959.6 Underlying: Common Stock · 2.7 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F3 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F3 · derivative.exercise_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F3 · derivative.expiration_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. Read SEC document |
| December 11, 2018 Filed Dec 13, 2018 21:42 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-007923 · doc1.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150.3 Underlying: Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously vested RSUs for which the Reporting Person has elected to defer delivery of shares. Such additional RSUs are fully vested on grant and will settle, together with the previously vested underlying RSUs to which they relate, on the applicable deferred delivery date. F2 · derivative.exercise_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously vested RSUs for which the Reporting Person has elected to defer delivery of shares. Such additional RSUs are fully vested on grant and will settle, together with the previously vested underlying RSUs to which they relate, on the applicable deferred delivery date. F2 · derivative.expiration_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously vested RSUs for which the Reporting Person has elected to defer delivery of shares. Such additional RSUs are fully vested on grant and will settle, together with the previously vested underlying RSUs to which they relate, on the applicable deferred delivery date. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 14:53 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.4 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-002506 · doc1.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,956.9 Underlying: Common Stock · 2.4 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F3 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F3 · derivative.exercise_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F3 · derivative.expiration_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 14:53 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.7 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-002506 · doc1.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,147.3 Underlying: Common Stock · 2.7 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously vested RSUs for which the Reporting Person has elected to defer delivery of shares. Such additional RSUs are fully vested on grant and will settle, together with the previously vested underlying RSUs to which they relate, on the applicable deferred delivery date. F2 · derivative.exercise_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously vested RSUs for which the Reporting Person has elected to defer delivery of shares. Such additional RSUs are fully vested on grant and will settle, together with the previously vested underlying RSUs to which they relate, on the applicable deferred delivery date. F2 · derivative.expiration_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously vested RSUs for which the Reporting Person has elected to defer delivery of shares. Such additional RSUs are fully vested on grant and will settle, together with the previously vested underlying RSUs to which they relate, on the applicable deferred delivery date. Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 20:38 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.5 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-028423 · doc1.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,954.5 Underlying: Common Stock · 2.5 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F3 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F3 · derivative.exercise_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. F3 · derivative.expiration_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 8, 2018 (the "2018 RSUs"). These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2018 RSUs, which will vest on May 8, 2019, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2018 RSUs. Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 20:38 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.7 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-028423 · doc1.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,144.6 Underlying: Common Stock · 2.7 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously vested RSUs for which the Reporting Person has elected to defer delivery of shares. Such additional RSUs are fully vested on grant and will settle, together with the previously vested underlying RSUs to which they relate, on the applicable deferred delivery date. F2 · derivative.exercise_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously vested RSUs for which the Reporting Person has elected to defer delivery of shares. Such additional RSUs are fully vested on grant and will settle, together with the previously vested underlying RSUs to which they relate, on the applicable deferred delivery date. F2 · derivative.expiration_date: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously vested RSUs for which the Reporting Person has elected to defer delivery of shares. Such additional RSUs are fully vested on grant and will settle, together with the previously vested underlying RSUs to which they relate, on the applicable deferred delivery date. Read SEC document |
| May 08, 2018 Filed May 9, 2018 20:34 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 1,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022513 · doc1.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,952 Underlying: Common Stock · 1,952 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (each, an "RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vest on May 8, 2019. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F2 · derivative.expiration_date: The RSUs vest on May 8, 2019. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| May 01, 2018 Filed May 3, 2018 23:04 UTC | Carlyle Group Inc. CG · Entity 3316 | GrantCommon Units | 5,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011393 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,103 F1 · shares: These securities are deferred restricted common unit awards granted under The Carlyle Group L.P. 2012 Equity Incentive Plan. These securities will vest on May 1, 2019, subject to Mr. Welters's continued service on the board of directors of Carlyle Group Management L.L.C., the general partner of The Carlyle Group L.P., on such vesting date. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:40 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.6 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-013672 · doc1.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,141.9 Underlying: Common Stock · 2.6 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 9, 2017 (the "2017 RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 18:32 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Disposition to issuerShare Equivalent Units · Derivative | 17,808 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-18-000467 · doc4.xml · derivative · entry 4 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,808 shares Expires not disclosed F7 · security: Units granted under the Company's Stock Equivalent Plan for Outside Directors. F3 · derivative.exercise_price: Conversion is 1 for 1. F8 · price: These units, which are 100% vested, were assumed by BD at the effective time of the Merger. F8 · derivative.exercise_date: These units, which are 100% vested, were assumed by BD at the effective time of the Merger. F8 · derivative.expiration_date: These units, which are 100% vested, were assumed by BD at the effective time of the Merger. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 18:32 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Disposition to issuerPhantom Stock Units · Derivative | 20,596.9 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-18-000467 · doc4.xml · derivative · entry 3 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,596.9 shares Expires not disclosed F2 · security: Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees. F3 · derivative.exercise_price: Conversion is 1 for 1. F6 · price: These units, which are 100% vested, were paid out in cash in accordance with the Merger Agreement. F6 · derivative.exercise_date: These units, which are 100% vested, were paid out in cash in accordance with the Merger Agreement. F6 · derivative.expiration_date: These units, which are 100% vested, were paid out in cash in accordance with the Merger Agreement. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 18:32 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GrantPhantom Stock Units · Derivative | 83.42 | $331.24 | $27,632.04 |
DisclosureSEC source: 0001225208-18-000467 · doc4.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,596.9 Underlying: Common Stock · 83.42 shares Expires not disclosed F2 · security: Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees. F3 · derivative.exercise_price: Conversion is 1 for 1. F4 · derivative.exercise_date: Phantom stock units are settled in cash upon termination of service as director. F4 · derivative.expiration_date: Phantom stock units are settled in cash upon termination of service as director. F5 · balance_after: Includes 32.86 units for dividend credits. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 18:32 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Disposition to issuerCommon Stock | 4,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000467 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 15:04 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.7 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-046169 · doc1.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,139.3 Underlying: Common Stock · 2.7 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 9, 2017 (the "2017 RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. Read SEC document |
| December 04, 2017 Filed Dec 5, 2017 15:05 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GrantShare Equivalent Units · Derivative | 245 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018188 · doc4.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,808 Underlying: Common Stock · 245 shares Expires not disclosed F2 · security: Units granted under the Company's Stock Equivalent Plan for Outside Directors. F3 · derivative.exercise_price: Conversion is 1 for 1. F4 · derivative.exercise_date: Share Equivalent Units are settled in cash upon termination as a director. F4 · derivative.expiration_date: Share Equivalent Units are settled in cash upon termination as a director. Read SEC document |
| December 04, 2017 Filed Dec 5, 2017 15:05 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GrantCommon Stock | 298 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018188 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,520 F1 · kind: Stock award granted in accordance with the 2005 Directors' Stock Award Plan, as amended and restated, that fully vests in three years from the date of grant, subject to earlier acceleration. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.